The Breast Cancer Journey is a multifaceted exploration of breast cancer and its impact on health care professionals, patients, research, therapy, finances, and policy. Join us as we examine the latest advances and controversies in the diagnosis and treatment of breast cancer, the identification and use of biomarkers to guide treatment decisions, and the experiences of patients and health care professionals managing this challenging disease.
The Breast Cancer Journey is associated with MDedge Hematology & Oncology, the source for timely, relevant, evidence-based, practice-changing information for hematologist-oncologists and medical oncologists. Readily accessible, interactive formats make MDedge Hematology & Oncology the best way for busy specialists to stay up to date and gain the perspectives they need to provide state-of-the-art care that improves patient outcomes.
MDedge Hematology & Oncology (www.mdedge.com/hematology-oncology) is owned by Frontline Medical Communications.
About Frontline Medical Communications
Frontline Medical Communications (Frontline) serves more than 1.2 million physicians and other health care professionals with diverse print and interactive multimedia products and platforms, and live events.
More than 30 enduring specialty journal brands offer a powerful synergy, including indexed, clinical, practical, and daily news content in the following fields:
Editor, MDedge Hematology/Oncology
ADVERTISING AND BUSINESS SERVICES